2012 Scientific Report - Queensland Children's Medical Research ...

esistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae
H041 strain. Journal of Antimicrobial Chemotherapy 2012; 67:902-905.
19. Sheridan S, Lambert S, Grimwood K. Impact of rotavirus vaccination on childhood
gastroenteritis. Microbiology Australia 2012; 33:56-60.
20. Sheridan SL, Lambert SB. Australian immunisation registers: established foundations
and opportunities for improvement. [Letter]. Eurosurveillance 2012; 17:pii=20177.
21. Bryant KA, McVernon J, Marchant CD, Nolan TM, Marshall GS, Richmond P, Marshall H,
Nissen MD, Lambert SB, Aris E, Mesaros N, Miller JM. Immunogenicity and safety of
measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of
Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus
toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials. Human
Vaccines and Immunotherapeutics 2012; 8: 1036-1041.
22. Howard P, McCaw JM, Richmond P, Nissen M, Sloots T, Lambert SB, Lai M, Greenberg
M, Nolan T, McVernon J. Virus detection and symptom severity during influenza-like
illness in a population sample of healthy adults. Influenza and other respiratory viruses
2012; doi:10.1111/j.1750-2659.2012.00395.x.
23. Mackay IM, Lambert SB, Faux CE, Allen KM, Nissen MD, Sloots TP, Nolan TM.
Community-wide, contemporaneous circulation of a broad spectrum of human
rhinoviruses in healthy Australian preschool-aged children during a 12-month period.
Journal of Infectious Diseases 2012; doi:10.1093/infdis/jis476.
24. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell
pertussis vaccines in infancy and disease protection. Journal of the American Medical
Association 2012; 308:454-456.
25. Richmond P, Nissen M, Marshall H, Lambert S, Roberton D, Gruber W, Jones T, Arora
A. A bivalent Neisseria meningitidis recombinant lipidated Factor H Binding Protein
vaccine in young adults: results of a randomised, controlled, dose-escalation Phase 1
trial. Vaccine 2012; 30:6163-6174.
26. Lambert SB. Postherpetic neuralgia after Herpes Zoster vaccination. [Letter]. Journal
of the American Medical Association 2012; 308:1427.
27. Goire N, Freeman K, Lambert SB, Nimmo GR, Limnios AE, Lahra MM, Nissen MD, Sloots
TP, Whiley DM. The influence of target population on non-culture based detection of
markers of Neisseria gonorrhoeae antimicrobial resistance. Sexual Health 2012; 9:422-
429.
28. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Unexpectedly limited durability of
immunity following acellular pertussis vaccination in preadolescents in a north
American outbreak. [Letter]. Clinical Infectious Diseases 2012; 55:1434-1435.
29. Lambert SB, Sheridan SL, Grimwood K. Canadian rotavirus vaccine effectiveness data.
[Letter]. Canadian Family Physician 2012; 58:1081.
30. Lambert SB, Ware RS, Cook AL, Maguire FA, Whiley DM, Bialasiewicz S, Mackay IM,
Wang D, Sloots TP, Nissen MD, Grimwood K. Observational Research in Childhood
QCMRI Scientific Report 2012 103